Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema

Lymphedema Clinical Trial

Official title:

Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06188858
• Other study ID #: Taizhou Hospital OISD
• Status: Completed
• Start date: January 1, 2020
• Est. completion date: December 1, 2023

Study information

• Verified date: December 2023
• Source: Taizhou Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Our aim was to identify optimal incision sites for LVA in extremity lymphedema that would result in the most effective drainage effect for reducing limb edema and enhancing patients' quality of life.

Description:

designing the optimal incision sites and identifying functional lymphatic vessels imaging is crucial for success, primarily due to its efficacy in draining edematous lymphatic fluid and reducing swelling in patients with lymphedema. In this study, we conducted patients with LVA lymphedema to investigate the correlation between LVA incision design, intraoperative functional lymphatic vessel assessment, postoperative limb reduction, and patient satisfaction.

question 1：Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema

Recruitment information / eligibility

• Status: Completed
• Enrollment: 267
• Est. completion date: December 1, 2023
• Est. primary completion date: December 1, 2023
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria: Aged 18-80 years; Lymphedema and swelling of the limbs for more than 3 months

-

Exclusion Criteria:

• lipedema;myoedema

Related Conditions & MeSH terms

• Lymphedema

Locations

Country	Name	City	State
China	Chong Liu	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Taizhou Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants with lymphedema stage	stage 0-3	through study completion, an average of 4 year
Primary	Number of Optimal Incision Site Design	Optimal Incision Site Design for Lymphaticovenular Anastomosis	through study completion, an average of 4 year
Primary	Rate of lymphatic vessel Functional Parameters	intraoperative functional lymphatic vessel assessment	through study completion, an average of 4 year
Primary	Circumferential Reduction rate	postoperative limb reduction and patient satisfaction	through study completion, an average of 4 year